Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction

NCT01912222 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Hematologic Malignancies

Interventions

DRUG: IXAZOMIB

Sponsor

Millennium Pharmaceuticals, Inc.